source
- Novartis-partnered Matchpoint Therapeutics raises $150 million Series B to fund clinical entryMatchpoint Therapeutics, a biotech company working with Novartis, announced the close of a new financing round. The round raised $150 million in Series B funding. The capital will be used to advan…
- Forbion secures $2.6 billion in its biggest European venture fund to dateForbion, a leading European venture capital firm, announced it has closed a $2.6 billion fund, the largest it has raised and among the biggest recent funds in the region. The new capital will be d…